参考文献
[1]Mant J,Fletcher K,Poalfe A et al,Warfarin verus aspirin for stroke prevention in an eldly community population with atrial fibrillation(The Bim ingham atrial fibrillation treatment of the aged study,BAFTA)a random ised controlled trial[J],Lancet,2007,370,493-503,
[2]Stangier J,Rathgen K,Stahle H,etal,The pharmacokinetics,pharmacodynamics and tolerability of dabigatran etexilate,a new oral direct thrombin inhibitor,in healthy male subjects[J],Br JClin Pharmacol,2007,64(3):292-303,
[3]Eriksson BI,Quinlan DJ,Weitz JI,Comparative pharmacodynamics and pharmacokinetics of oral direct thrombin and factor xa inhibitors in development[J],Clin Pharmacokinet,2009,48(1):1-22,
[4]Kubitza D,Becka M,Roth A,et al,Dose-escalation study of the pharmacokinetics and pharmacodynamics of rivaroxaban in healthy elderly subjects[J],Curr Med Res Opin,2008,24(10):2757-2765,
[5]Gross PL,Weitz JI,New anticoagulants for treatment of venous thromboembolism[J],Arterioscler Thromb Vasc Biol,2088,28(3):380-386,
[6]Yuan HY,Chen JJ,Lee MT et al,A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differentces in warfarin sensitivity,Hum Mol Genet,2005 Jul 1,14(13):1745-51,Epub 2005 May 11,
[7]Zhu Y,Shennan M,Reynolds KK et al,Estimation ofWarfarin Maintena-nce Dose Based on VKORC1(639 GA)and CYP2C9 Genotypes,Clin Chem,2007 Jul,53(7):1199-205,Epub 2007 May 17,
[8]Veenstra DL,You JH,RiederMJ,et al,Association of VitaminK epoxide reductase complex 1(VKORC1)variantswithwarfarin dose in a Hong Kong Chinese patientpopulation,Harmacogenet Genomics,2005,15(10):687-691,(https://www.daowen.com)
[9]吴小盈，章伟平，陈慧等，VKORC1-1639 G/A基因多态性与华法林应用剂量关系的研究 [J]，中华临床医师杂志，2008，2（3）：271-275，
[10]Tabrizi AR,Zelinbauer BA,Boreeki IB,et al,The frequency and effects of cytochrome P45O(CYP)2C9 polymophism in patients receiving warfarin[J],J Am Coll Surg,2002,194:267-273,
[11]Miao L,Yang J,Huang C,et al,Contribution of age,body Weight,and CYP2C9 and VKORCI genotype to the anticoagulantresponse to warfarin:proposal for a new dosing regimen in Chinese patients[J],Eur JClin Pharmacol,2007,63(12):1135-1141,
[12]葛蓓蕾，田陆云，郝萍等，VKORC1-1639 G/A基因多态性及其他因素对老年患者华法林维持剂量的影响 [J]，中国老年学杂志，2013，12（33）：6076-6078，
（王红 田陆云 郝萍）